Previous studies have shown altered AA metabolites in NASH patients, reduced CYP2J2 expression in high-fat diet (HFD)-induced NASH mice (26), decreased EETs (15), and increased sEH (32) in NASH mice. The gene discussed is CYP2J2; the disease is metabolic dysfunction-associated steatohepatitis.